Titre :
  • Phase I and pharmacokinetic study of the oral farnesyl transferase inhibitor SCH 66336 given twice daily to patients with advanced solid tumors.
Auteur : Eskens, Ferry ALM ; Awada, Ahmad ; Cutler, D L ; de Jonge, M J ; Luyten, G P ; Faber, Marije ; Statkevich, Paul ; Sparreboom, A ; Verweij, Jaap ; Hanauske, Axel-R ; Piccart-Gebhart, Martine ; European Organization for Research and Treatment of Cancer Early Clinical Studies Group
Informations sur la publication : Journal of clinical oncology, 19, 4, (page 1167-1175)
Statut de publication : Publié, 2001-02
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Administration, Oral
Adult
Aged
Alkyl and Aryl Transferases -- antagonists & inhibitors
Antineoplastic Agents -- administration & dosage
Antineoplastic Agents -- pharmacokinetics
Antineoplastic Agents -- therapeutic use
Enzyme Inhibitors -- administration & dosage
Enzyme Inhibitors -- pharmacokinetics
Enzyme Inhibitors -- therapeutic use
Farnesyltranstransferase
Female
Humans
Male
Middle Aged
Piperidines -- pharmacokinetics
Piperidines -- therapeutic use
Pyridines -- pharmacokinetics
Pyridines -- therapeutic use
Note : Clinical Trial
Clinical Trial, Phase I
Journal Article
Langue :
  • Anglais
Identificateurs : urn:issn:0732-183X 
info:pmid/11181683